• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Indivior - Articles and news items

RBP-7000-indivior

Positive top-line results from Phase 3 trial of RBP-7000 in schizophrenia announced

Industry news / 6 May 2015 / Victoria White

Indivior has announced top-line results from its Phase 3 clinical trial of RBP-7000, an investigational drug for the treatment of schizophrenia…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +